FR Imrie, AD Dick - Current Opinion in Ophthalmology, 2007 - journals.lww.com Purpose of review This review summarizes current nonsteroidal drug therapies for
noninfectious posterior and intermediate uveitis. Recent findings Continuing
evidence shows that second-line agents including antimetabolites, T-cell ... Cited by 9 - Related articles - BL Direct - All 2 versions
- ►prsjournal.com A Rothova - Current Opinion in Ophthalmology, 2007 - journals.lww.com Purpose of review The aim of this article is to update our current understanding
and management of inflammatory cystoid macular edema. Recent findings Cystoid
macular edema is a common cause of visual loss in uveitis, which occurs ... Cited by 9 - Related articles - BL Direct - All 6 versions
NR Acharya, KC Hong, SM Lee - American Journal of Ophthalmology, 2009 - Elsevier Seven consecutive patients with controlled uveitis and refractory CME who had
failed corticosteroid treatment were studied. One eligible patient chose not to
participate and another did not complete follow-up for nonmedical reasons. ... Cited by 1 - Related articles - All 21 versions
- ►duanesolution.com [PDF] SM Maca, C Abela-Formanek, CG Kiss, SG … - Clinical & Experimental Ophthalmology, 2009 - pt.wkhealth.com Results:: Between March 2003 and May 2006, 24 eyes of 18 patients received
between one and three IVTA injections. A resolution of chronic CMO was observed
in 7/24 eyes (29.2%, 5 eyes after single injection of IVTA, 1 eye each ... Related articles - All 5 versions
S Schaal, TH Tezel, HJ Kaplan - Ocular Immunology and Inflammation, 2008 - informahealthcare.com It is thought that CME associated with uveitis is due to the disruption of the
tight intercellular junctions in either the inner blood–retinal or the outer
retinal-RPE barrier caused by intraocular inflammation. Recent studies have ... Related articles - All 3 versions